Back to search

Netherlands· NL-ab22144923e9

Havrix Junior, suspensie voor injectie

A hepatitis a, inaktiviert, ganzes virus product containing hepatitis a virusantigeen, geinactiveerd, stam hm175, registered in Netherlands by GlaxoSmithKline B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC J07BC02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedHavrix Junior, suspensie voor injectieATCJ07BC02REGISTER NO.NL-ab22144923e9PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Hepatitis a, inaktiviert, ganzes virus is registered in 11 of 19 countries.

Countries holding a registration under ATC J07BC02 (hepatitis a, inaktiviert, ganzes virus), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose

Hepatitis a, inaktiviert, ganzes virus · ATC J07BC02

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
HEPATITIS A VIRUSANTIGEEN, GEINACTIVEERD, Stam HM175
Manufacturer
GlaxoSmithKline B.V.
Country
Netherlands (NL)
ATC code
J07BC02
ATC class
Hepatitis A, inaktiviert, ganzes Virus
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    135314

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c3a97665-ea04-49b0-a0a8-0ed07984621f
GET /v1/drugs/c3a97665-ea04-49b0-a0a8-0ed07984621f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspensie voor injectie",
  "route": null,
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h135314_smpc.pdf",
  "strength": null,
  "atc_label": "Hepatitis A, Inactivated, Whole Virus",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg135314",
  "excipients": [
    "ALUMINIUMHYDROXIDE, GEHYDRATEERD, VOOR ADSORPTIE",
    "AMINOZUREN (AANTAL 15)",
    "DINATRIUMWATERSTOFFOSFAAT 2-WATER (E 339)",
    "KALIUMCHLORIDE (E 508)",
    "KALIUMDIWATERSTOFFOSFAAT 0-WATER (E 340)",
    "NATRIUMCHLORIDE",
    "POLYSORBAAT 20 (E 432)",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "HEPATITIS A VIRUSANTIGEEN, GEINACTIVEERD, Stam HM175"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h135314.pdf",
  "authorised_at": "2025/03/06",
  "procedure_number": "BE/H/0388/003",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "135314",
  "additional_monitoring": "N"
}

See everything about hepatitis a, inaktiviert, ganzes virus.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.